Kumar Narinder, Jafri M A, Vignesh S
Apollo Medics Hospital, Lucknow, India.
Department of Orthopaedics, Base Hospital Delhi Cantt, New Delhi, India.
J Orthop. 2025 May 8;64:182-188. doi: 10.1016/j.jor.2025.05.014. eCollection 2025 Jun.
Venous thromboembolism (VTE) is a significant and serious complication occurring after lower limb arthroplasty surgeries, increasing morbidity and mortality. It is estimated that almost half of lower limb arthroplasty patients might develop deep vein thrombosis (DVT) without adequate prophylaxis. Pulmonary embolism (PE) is a possible consequence of DVT and leads to increased perioperative mortality rates after total joint replacements. It is therefore imperative to develop a standard guideline for thromboprophylaxis for lower limb arthroplasty patients. Non availability of sensitive and specific diagnostic methods in the post-operative period further adds to the problem. Non-invasive diagnostic modalities such as compression ultrasonography (USG), real-time B mode compression and colour Doppler USG are generally preferred over invasive modality such as venography which is considered to be the gold standard. Thromboprophylaxis can be achieved by pharmacological as well as nonpharmacological means. However, no consensus exists on the ideal thromboprophylaxis method.
In this study, we have used aspirin as a single chemoprophylactic agent in patients of total knee replacement for the prophylaxis of symptomatic deep vein thrombosis for all patients with addition of mechanical prophylaxis as per risk stratified approach recommended by the AAOS. A total of 50 patients meeting the predefined selection criteria were enrolled for the study. Effectiveness of the same was measured by clinical & radiological assessment.
We found that aspirin as a chemical monoprophylaxis along with mechanical methods lead to total risk mitigation for VTE in 98 % of our study population. There was one case of distal DVT (2 %) which was successfully managed by pharmacotherapy.
Use of aspirin as a monoprophylaxis against DVT and PE is effective in patients undergoing total knee arthroplasty. Addition of a mechanical prophylaxis might be considered in higher risk patients.
静脉血栓栓塞症(VTE)是下肢关节置换术后发生的一种严重并发症,会增加发病率和死亡率。据估计,几乎一半的下肢关节置换患者在没有充分预防措施的情况下可能会发生深静脉血栓形成(DVT)。肺栓塞(PE)是DVT的一种可能后果,会导致全关节置换术后围手术期死亡率增加。因此,为下肢关节置换患者制定血栓预防的标准指南势在必行。术后缺乏敏感和特异的诊断方法进一步加剧了这一问题。与被视为金标准的侵入性检查方法如静脉造影相比,非侵入性诊断方法如压迫超声检查(USG)、实时B模式压迫和彩色多普勒USG通常更受青睐。血栓预防可以通过药物和非药物手段实现。然而,对于理想的血栓预防方法尚无共识。
在本研究中,我们将阿司匹林作为单一化学预防药物用于全膝关节置换患者,按照美国矫形外科医师学会(AAOS)推荐的风险分层方法,为所有患者添加机械预防措施,以预防有症状的深静脉血栓形成。共有50名符合预定义选择标准的患者纳入本研究。通过临床和影像学评估来衡量其有效性。
我们发现,阿司匹林作为化学单一预防药物并结合机械方法,使我们研究人群中98%的VTE总风险得到缓解。有1例远端DVT(2%)通过药物治疗成功处理。
阿司匹林作为预防DVT和PE的单一药物,在接受全膝关节置换术的患者中是有效的。对于高风险患者,可考虑添加机械预防措施。